An estimated one in five U.S. adults has tried a GLP-1 for managing weight loss or diabetes. And now, more kids struggling with obesity are taking the medication, too. Pediatric doctors say early intervention with GLP-1s can prevent lifelong obesity, Type 2 diabetes and high blood pressure but want more research into the effects on developing bodies. We’ll discuss the new medical landscape and how doctors and parents are navigating it.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Podden och tillhörande omslagsbild på den här sidan tillhör
KQED. Innehållet i podden är skapat av KQED och inte av,
eller tillsammans med, Poddtoppen.
